We are live on ! Find out more
OTLK icon

Outlook Therapeutics
OTLK

76 hedge funds and large institutions have $29.3M invested in Outlook Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 18 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 18

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

16% more capital invested

Capital invested by funds: $25.3M → $29.3M (+$4.01M)

1% more funds holding

Funds holding: 75 → 76 (+1)

0.02% less ownership

Funds ownership: 0.55% → 0.53% (-0.02%)

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
26
Reduced
18
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$188K
2
AA
Ancora Advisors
Ohio
+$101K
3
State Street
State Street
Massachusetts
+$69.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$41.7K
5
Squarepoint
Squarepoint
New York
+$37.3K

Top Sellers

Rank Fund Capital Flow
1
VF
Vista Finance
Missouri
-$724K
2
Renaissance Technologies
Renaissance Technologies
New York
-$187K
3
Millennium Management
Millennium Management
New York
-$183K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$179K
5
BlackRock
BlackRock
New York
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$69K +$930 +40 +1%
FCC
27
Flower City Capital
New York
$63K – – –
Renaissance Technologies
28
Renaissance Technologies
New York
$61K -$187K -8,055 -76%
Deutsche Bank
29
Deutsche Bank
Germany
$61K -$9.21K -396 -14%
VOYA Investment Management
30
VOYA Investment Management
Georgia
$57.3K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$57K -$4.53K -195 -8%
Invesco
32
Invesco
Georgia
$55K +$7.18K +309 +16%
TRCT
33
Tower Research Capital (TRC)
New York
$51K +$30.2K +1,298 +161%
GL
34
Graypoint LLC
New York
$46K – – –
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$44K +$349 +15 +0.8%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$44K +$41.7K +1,795 New
AllianceBernstein
37
AllianceBernstein
Tennessee
$41K +$5.81K +250 +18%
Citadel Advisors
38
Citadel Advisors
Florida
$40K +$25.9K +1,112 +211%
Squarepoint
39
Squarepoint
New York
$39K +$37.3K +1,605 New
Envestnet Asset Management
40
Envestnet Asset Management
Illinois
$35K +$4.46K +192 +16%
SG Americas Securities
41
SG Americas Securities
New York
$30K +$8.39K +361 +41%
ACM
42
Alamar Capital Management
California
$29K +$4.07K +175 +18%
Creative Planning
43
Creative Planning
Kansas
$28K – – –
William Blair & Company
44
William Blair & Company
Illinois
$28K – – –
AB
45
Amalgamated Bank
New York
$22K +$349 +15 +2%
OC
46
Oppenheimer & Co
New York
$22K +$4.65K +200 +29%
Principal Financial Group
47
Principal Financial Group
Iowa
$21K -$1.51K -65 -7%
MGP
48
Metis Global Partners
California
$21K – – –
T. Rowe Price Associates
49
T. Rowe Price Associates
Maryland
$21K +$6.28K +270 +48%
PAM
50
PVG Asset Management
Colorado
$20.1K +$19.1K +823 New
1
2
3 4

OTLK Hedge Fund Activity: Q3 2022 in Review

76 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Outlook Therapeutics (OTLK) for Q3 2022, worth a combined $29.3M — up 16% from $25.3M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new OTLK positions and 5 closed out — a net gain of 2 holders — while 26 added to existing stakes and 18 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $188K. The largest seller was Vista Finance, cutting an estimated $724K.

  • 76 institutional investors held Outlook Therapeutics (OTLK) as of Q3 2022, up from 75 in Q2 2022.
  • Funds reported $29.3M of Outlook Therapeutics stock for Q3 2022, up 16% quarter-over-quarter.
  • 7 funds opened new Outlook Therapeutics positions in Q3 2022 and 5 closed out, a net change of +2 holders.
  • The largest Outlook Therapeutics buyer in Q3 2022 was Fidelity Investments, an estimated $188K added.
  • The largest Outlook Therapeutics seller in Q3 2022 was Vista Finance, an estimated $724K sold.

Based on aggregated 13F filings for Q3 2022.